07:00 , Oct 10, 2005 |  BC Week In Review  |  Company News

Ascentia Biomedical scientific advisory board update

Ascentia Biomedical Corp. (ASCE), Bellevue, Wash.   Business: Cancer, Inflammation, Supply/Service   Appointed: Philip Mease, clinical professor at the University of Washington  ...
07:00 , Aug 22, 2005 |  BC Week In Review  |  Company News

Ascentia Biomedical, University of Washington deal

ASCE received an option from the university to license an undisclosed family of compounds. The option includes preclinical compounds for breast cancer, sepsis and arthritis. Ascentia Biomedical Corp. (ASCE), Bellevue, Wash.   University of Washington...
07:00 , Jul 11, 2005 |  BC Week In Review  |  Company News

Ascentia Biomedical scientific advisory board update

Ascentia Biomedical Corp. (ASCE), Bellevue, Wash.   Business: Cancer, Autoimmune   Appointed: Emil Chi, professor of pathology at the University of Washington, as chairman; Robert Reife, CSO at ASCE; Richard Darveau, professor of periodontics, oral...